PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

CPhI Worldwide opens entries for 15th Annual Pharma Awards

Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives CPhI Worldwide – organised by UBM (part of Informa PLC) – anno...
Continue Reading →
News

A dose of history: which drugs have truly changed the world?

?     Pharmacy2U launches a new interactive timeline celebrating the most important medical discoveries and drugs that changed the face of medici...
Continue Reading →
News

Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market

Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, the calScreener™ – has announced the appointment of t...
Continue Reading →
News

bioLIVE report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve bio process manufacturing efficiency

A report from bioLIVE – the new UBM biomanufacturing and bioprocessing event taking place in Madrid (October 9-11, 2018) – has collected findings from a panel of exp...
Continue Reading →
News

FDA Grants QIDP Designation to Acurx's Lead Antibiotic Product Candidate, ACX-362E for Clostridium Difficile Infection

Acurx Pharmaceuticals, LLC ("Acurx" or the "Company"), a privately held clinical stage biopharmaceutical company focused on developing new antibiotics for difficul...
Continue Reading →
News

New Diagnostic Tool for Heart Disease Based on CRISPR Technology

Researchers at Stanford University developed the tool, which combines gene editing and disease modeling. Of the 135 genes associated with cardiomyopathy and congenit...
Continue Reading →
News

Cellectic CAR-T Therapy Contains Safety Switch and More

CubiCAR cells are designed to be killed by the monoclonal antibody, rituximab, in patients with an overactive immune response.  Many different approaches to the...
Continue Reading →
News

Aptar Pharma’s Preservative-Free Multidose Dispenser Approved for Anti-Allergy Treatment by French Regulatory Agency ANSM

Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved delivery device for Bausch+Lomb’s Levofree Multidose in Franc...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026